|
1
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karavitakis M, Msaouel P, Michalopoulos V
and Koutsilieris M: Pattern of somatostatin receptors expression in
normal and bladder cancer tissue samples. Anticancer Res.
34:2937–2942. 2014.PubMed/NCBI
|
|
4
|
Eisenberg MS, Boorjian SA, Cheville JC,
Thompson RH, Thapa P, Kaushik D and Frank I: The SPARC score: A
multifactorial outcome prediction model for patients undergoing
radical cystectomy for bladder cancer. J Urol. 190:2005–2010. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
James ND, Hussain SA, Hall E, Jenkins P,
Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T,
Hendron C, et al: Radiotherapy with or without chemotherapy in
muscle-invasive bladder cancer. N Engl J Med. 366:1477–1488. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen Y, Wang X, Jin Y, Lu J, Qiu G and Wen
X: Differentially expressed genes and interacting pathways in
bladder cancer revealed by bioinformatic analysis. Mol Med Rep.
10:1746–1752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou N, Singh K, Mir MC, Parker Y, Lindner
D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A and Hansel DE:
The investigational aurora kinase a inhibitor MLN8237 induces
defects in cell viability and cell-cycle progression in malignant
bladder cancer cells in vitro and in vivo. Clin Cancer Res.
19:1717–1728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Z, Furge KA, Yang XJ, Teh BT and
Hansel DE: Comparative gene expression profiling analysis of
urothelial carcinoma of the renal pelvis and bladder. BMC Med
Genomics. 3:582010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smyth GK: Limma: Linear models for
microarray dataBioinformatics and computational biology solutions
using R and Bioconductor. Springer; New York, NY: pp. 397–420.
2005, View Article : Google Scholar
|
|
11
|
Chen H and Boutros PC: VennDiagram: A
package for the generation of highly-customizable Venn and Euler
diagrams in R. BMC Bioinformatics. 12:352011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wickham H: ggplot2: Elegant graphics for
data analysis. Springer; New York, NY: 2009, View Article : Google Scholar
|
|
13
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for Gene Ontology
analysis. BMC Proc. 3 Suppl 4:S102009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galperin MY and Fernández-Suárez XM: The
2012 nucleic acids research database issue and the online molecular
biology database collection. Nucleic Acids Res. 40:(Database
Issue). D1–D8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martin A, Ochagavia ME, Rabasa LC, Miranda
J, Fernandez-de-Cossio J and Bringas R: BisoGenet: A new tool for
gene network building, visualization and analysis. BMC
Bioinformatics. 11:912010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bader GD, Betel D and Hogue CW: BIND: The
biomolecular interaction network database. Nucleic Acids Res.
31:248–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nepusz T, Yu H and Paccanaro A: Detecting
overlapping protein complexes in protein-protein interaction
networks. Nat Methods. 9:471–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mulac-Jericevic B and Conneely OM:
Reproductive tissue selective actions of progesterone receptors.
Reproduction. 128:139–146. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miyamoto H, Yang Z, Chen YT, Ishiguro H,
Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, et al:
Promotion of bladder cancer development and progression by androgen
receptor signals. J Natl Cancer Inst. 99:558–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De León-Nava MA, Nava K, Soldevila G,
López-Griego L, Chávez-Ríos JR, Vargas-Villavicencio JA and
Morales-Montor J: Immune sexual dimorphism: Effect of gonadal
steroids on the expression of cytokines, sex steroid receptors, and
lymphocyte proliferation. J Steroid Biochem Mol Biol. 113:57–64.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Loyola A and Almouzni G: Histone
chaperones, a supporting role in the limelight. Biochim Biophys
Acta. 1677:3–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vaquero A, Loyola A and Reinberg D: The
constantly changing face of chromatin. Sci Aging Knowledge Environ.
2003:RE42003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schneider AC, Heukamp LC, Rogenhofer S,
Fechner G, Bastian PJ, von Ruecker A, Müller SC and Ellinger J:
Global histone H4K20 trimethylation predicts cancer-specific
survival in patients with muscle-invasive bladder cancer. BJU Int.
108:E290–E296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim K, Punj V, Choi J, Heo K, Kim JM,
Laird PW and An W: Gene dysregulation by histone variant H2A.Z in
bladder cancer. Epigenetics Chromatin. 6:342013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Motohashi H, O'Connor T, Katsuoka F, Engel
JD and Yamamoto M: Integration and diversity of the regulatory
network composed of Maf and CNC families of transcription factors.
Gene. 294:1–12. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kyo M, Yamamoto T, Motohashi H, Kamiya T,
Kuroita T, Tanaka T, Engel JD, Kawakami B and Yamamoto M:
Evaluation of MafG interaction with Maf recognition element arrays
by surface plasmon resonance imaging technique. Genes Cells.
9:153–164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimokawa N, Kumaki I, Qiu CH, Ohmiya Y,
Takayama K and Koibuchi N: Extracellular acidification enhances DNA
binding activity of MafG-FosB heterodimer. J Cell Physiol.
205:77–85. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Avouac J, Palumbo K, Tomcik M, Zerr P,
Dees C, Horn A, Maurer B, Akhmetshina A, Beyer C, Sadowski A, et
al: Inhibition of activator protein 1 signaling abrogates
transforming growth factor β-mediated activation of fibroblasts and
prevents experimental fibrosis. Arthritis Rheum. 64:1642–1652.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gopalakrishnan A and Kong Tony AN:
Anticarcinogenesis by dietary phytochemicals: Cytoprotection by
Nrf2 in normal cells and cytotoxicity by modulation of
transcription factors NF-kappa B and AP-1 in abnormal cancer cells.
Food Chem Toxicol. 46:1257–1270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Borlado LR and Méndez J: CDC6: From DNA
replication to cell cycle checkpoints and oncogenesis.
Carcinogenesis. 29:237–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Brun C, Guénoche A and Jacq B: Approach of
the functional evolution of duplicated genes in Saccharomyces
cerevisiae using a new classification method based on
protein-protein interaction data. J Struct Funct Genomics.
3:213–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Korkolopoulou P, Givalos N, Saetta A,
Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E and
Patsouris E: Minichromosome maintenance proteins 2 and 5 expression
in muscle-invasive urothelial cancer: A multivariate survival study
including proliferation markers and cell cycle regulators. Human
Pathol. 36:899–907. 2005. View Article : Google Scholar
|
|
38
|
Murphy N, Ring M, Heffron CC, King B,
Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O and
O'Leary JJ: p16INK4A, CDC6, and MCM5: Predictive biomarkers in
cervical preinvasive neoplasia and cervical cancer. J Clin Pathol.
58:525–534. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Borlado LR and Méndez J: CDC6: From DNA
replication to cell cycle checkpoints and oncogenesis.
Carcinogenesis. 29:237–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yao Z and Mishra L: Cancer stem cells and
hepatocellular carcinoma. Cancer Biol Ther. 8:1691–1698. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Luo JH: Oncogenic activity of MCM7
transforming cluster. World J Clin Oncol. 2:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
